Skip to content

Zoetis Inc.

ZTS· NYSECore metricsCIK 1555280

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · +0.48%
Market cap
$33.71B
406.32M shares
Filings
1,062
$2.39B
Q3 2026+2.3% FY25 yoy
$591.00M
Q3 2026+7.5% FY25 yoy
—
—
—
$1.55B
Q3 2026derived−0.7% FY25 yoy
$1.44
Q3 2026+10.1% FY25 yoy
$1.33B
Q3 2026+23.3% FY25 yoy
$33.71B
13.4×
3.6×
10.2×
6.63%
—

Twelve months to Sep 30, 2026 · derived

Price

$82.9730.93%$37.14past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$9.47BFY 2025
$9.47B0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$9,467,000,000reported
FY 20242024-12-31$9,256,000,000reported
FY 20232023-12-31$8,544,000,000reported
FY 20222022-12-31$8,080,000,000reported
FY 20212021-12-31$7,776,000,000reported
FY 20202020-12-31$6,675,000,000reported
FY 20192019-12-31$6,260,000,000reported
FY 20182018-12-31$5,825,000,000reported
FY 20172017-12-31$5,307,000,000reported
FY 20162016-12-31$4,888,000,000reported
FY 20152015-12-31$4,765,000,000reported
FY 20142014-12-31$4,785,000,000reported

Capital returns

Dividends and buybacks · FY2016 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025—$3.24B$3.24B$2.03422.13M sh−5.7%141.7%
FY2024—$1.86B$1.86B$1.80447.79M sh−2.2%80.9%
FY2023—$1.09B$1.09B$1.56457.87M sh−1.2%67.4%
FY2022—$1.59B$1.59B$1.35463.39M sh−1.8%120.2%
FY2021—$743.00M$743.00M$1.08471.97M sh−0.7%42.8%

Segments

Revenue by Segments, FY2018 to FY2025FY2018United States Segment · FY2018 · $2.88BInternational Segment · FY2018 · $2.89BFY2019United States Segment · FY2019 · $3.20BInternational Segment · FY2019 · $2.97BFY2020United States Segment · FY2020 · $3.56BInternational Segment · FY2020 · $3.04BFY2021United States Segment · FY2021 · $4.04BInternational Segment · FY2021 · $3.65BFY2022United States Segment · FY2022 · $4.31BInternational Segment · FY2022 · $3.68BFY2023United States Segment · FY2023 · $4.56BInternational Segment · FY2023 · $3.91BFY2024United States Segment · FY2024 · $5.07BInternational Segment · FY2024 · $4.10BFY2025United States Segment · FY2025 · $5.10BInternational Segment · FY2025 · $4.25B
LineFY2025ShareChange
United States Segment$5.10B54%+0.5%
International Segment$4.25B45%+3.7%
Total$9.47B

From the 10-K filed Feb 12, 2026ZTS

Pharmaceutical preparations

Zoetis Inc. is the 15th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Zoetis Inc. · CIK 1555280 · Engraved from SEC EDGAR